Nitschke Amanda S, Karim Jalisa L, Vallance Bruce A, Bickford Celeste, Ip Angie, Lanphear Nancy, Lanphear Bruce, Weikum Whitney, Oberlander Tim F, Hanley Gillian E
School of Population and Public Health.
BC Children's Hospital Research Institute.
Pediatrics. 2022 Sep 1;150(3). doi: 10.1542/peds.2022-057346.
Antibiotics are commonly administered during labor and delivery, and research has suggested that fetal exposure to antibiotics can increase risk for autism spectrum disorder (ASD). We assessed whether antibiotic exposure during labor and delivery increased the risk of ASD in the offspring.
This retrospective cohort study included everyone who delivered a live singleton-term infant in British Columbia, Canada, between April 1, 2000, and December 31, 2014. This cohort included 569 953 deliveries. To examine the association among pregnant individuals being treated for the same indication, we studied a subcohort of those who tested positive for group B Streptococcus. Cox proportional hazards models were used to estimate unadjusted and adjusted hazard ratios in both cohorts. A sensitivity analysis was conducted using length of first stage of labor as a proxy measure for dose to assess for a dose-response relationship.
In this population-based study, antibiotic use during labor and delivery was not associated with an increased risk of ASD in offspring. The unadjusted and adjusted hazard ratios were 1.29 (95% confidence interval, 1.24-1.35) and 0.99 (0.94-1.04), respectively; and 1.07 (0.90-1.27) and 0.88 (0.74-1.05), respectively, in the group B Streptococcus-positive cohort. We observed no substantial difference in the association between antibiotic exposure and ASD depending on length of the first stage of labor.
Our findings suggest that concern for ASD should not factor into the clinical decision on whether to administer antibiotics during labor and delivery. Future research is needed to examine longer durations of prenatal antibiotic exposure.
抗生素在分娩期间普遍使用,研究表明胎儿接触抗生素会增加患自闭症谱系障碍(ASD)的风险。我们评估了分娩期间接触抗生素是否会增加后代患ASD的风险。
这项回顾性队列研究纳入了2000年4月1日至2014年12月31日期间在加拿大不列颠哥伦比亚省分娩单胎足月活产婴儿的所有人。该队列包括569953例分娩。为了研究因相同适应症接受治疗的孕妇之间的关联,我们研究了B族链球菌检测呈阳性的亚队列。使用Cox比例风险模型估计两个队列中未调整和调整后的风险比。进行了一项敏感性分析,使用第一产程长度作为剂量的替代指标来评估剂量反应关系。
在这项基于人群的研究中,分娩期间使用抗生素与后代患ASD的风险增加无关。在总体队列中,未调整和调整后的风险比分别为1.29(95%置信区间,1.24 - 1.35)和0.99(0.94 - 1.04);在B族链球菌阳性队列中,分别为1.07(0.90 - 1.27)和0.88(0.74 - 1.05)。根据第一产程长度,我们观察到抗生素暴露与ASD之间的关联没有实质性差异。
我们的研究结果表明,在决定分娩期间是否使用抗生素的临床决策中,不应考虑对ASD的担忧。需要进一步研究来检查产前抗生素暴露的更长持续时间。